Suspension of trading
Valuation Applied Therapeutics, Inc.
Stocks
APLT
US03828A1016
Biotechnology & Medical Research
|
Delayed
Nasdaq
16:00:00 2026-02-02 EST
|
5-day change | 1st Jan Change | ||
| 0.1030 USD | +0.19% |
|
-.--% | +3.00% |
| 02-03 | Cycle Group Holdings Limited completed the acquisition of Applied Therapeutics, Inc. for approximately $14.3 million. | CI |
| 02-03 | Applied Therapeutics, Inc. Announces Management Changes | CI |
Company Valuation: Applied Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 505.1 | 495 | 234.6 | 36.52 | 258.7 | 99.62 |
| Change | - | -2% | -52.6% | -84.43% | 608.33% | -61.49% |
| Enterprise Value (EV) 1 | 468.3 | 400.9 | 155.9 | 7.458 | 209.6 | 23.02 |
| Change | - | -14.38% | -61.11% | -95.22% | 2,710.44% | -89.02% |
| P/E | -7.69x | -5.15x | -2.17x | -0.35x | -2.36x | -1.13x |
| PBR | 15.5x | 6.04x | 3.75x | 8.99x | -16.6x | 2.06x |
| PEG | - | -0.3x | 0.61x | 0x | 0.1x | 0x |
| Capitalization / Revenue | - | - | - | - | 25,889,907x | 218,954,754x |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| EV / EBIT | -10.3x | -4.24x | -1.48x | -0.09x | -3.25x | -0.22x |
| EV / FCF | -24.9x | -9.31x | -3.07x | -0.22x | 27.1x | -0.25x |
| FCF Yield | -4.01% | -10.7% | -32.5% | -460% | 3.69% | -402% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -3.547 | -4.278 | -4.125 | -2.181 | -1.422 | -0.76 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | - | - | - | 9.993 | 0.455 |
| EBITDA | - | - | - | -82.95 | -64.53 | -104.3 |
| EBIT 1 | -45.58 | -94.47 | -105.6 | -82.95 | -64.54 | -104.3 |
| Net income 1 | -45.51 | -93.96 | -105.6 | -82.51 | -119.8 | -105.6 |
| Net Debt 1 | -36.82 | -94.02 | -78.7 | -29.07 | -49.12 | -76.6 |
| Reference price 2 | 27.2800 | 22.0100 | 8.9500 | 0.7600 | 3.3500 | 0.8562 |
| Nbr of stocks (in thousands) | 18,515 | 22,488 | 26,216 | 48,059 | 77,229 | 116,356 |
| Announcement Date | 3/13/20 | 3/18/21 | 3/10/22 | 3/23/23 | 3/6/24 | 4/15/25 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 15.7M | |
| 21.8x | 7.74x | 15.55x | 1.36% | 74.27B | |
| 31.81x | 9.18x | 28.6x | 0.04% | 61.21B | |
| 31.83x | 6.79x | 17.62x | -.--% | 27.55B | |
| -73.75x | 14.26x | -68.76x | -.--% | 26.38B | |
| -15.46x | 5.96x | -7.5x | -.--% | 25.34B | |
| 28.48x | 5.36x | 17.82x | -.--% | 20.84B | |
| 1066.25x | 37.33x | 644.76x | -.--% | 14.94B | |
| 43.75x | 16.03x | 32.53x | 0.34% | 15.17B | |
| 17.96x | 5.35x | 12.5x | -.--% | 14.41B | |
| Average | 128.07x | 12.00x | 77.01x | 0.19% | 28.01B | |
| Weighted average by Cap. | 69.79x | 10.14x | 43.06x | 0.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- APLT Stock
- Valuation Applied Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
